Immatics (IMTX) Divestments (2019 - 2024)

Immatics (IMTX) reported Divestments of $73.6 million for Q3 2024, up 195.8% on a YoY basis from $24.9 million in Q4 2023, and up 195.8% sequentially from -$76.8 million in Q3 2023.

Immatics (IMTX) Divestments (2019 - 2024) Analysis & Trends

Immatics (IMTX) has 5 years of Divestments data on file, last reported at $73.6 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -32.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Immatics 1.14 Bn 1.14 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 73.59 Mn
Sep 30, 2023 -76.82 Mn
Mar 31, 2021 3.09 Bn
Sep 30, 2020 -12.85 Bn
Jun 30, 2020 16.16 Bn
Mar 31, 2020 -21.22 Bn
Sep 30, 2019 14.30 Bn